MRNA
Moderna, Inc. · Healthcare
Director Noubar Afeyan sold $455.7M of Moderna, Inc.
Sold$455,692,554
$121.43Price
3,752,805Shares
−14%Stake
What MRNA did after the filing
- The stock from Thu, Apr 1 open, $132.20
- +22.1%
- S&P 500, same days
- +4.6%
Measured over 30 trading days, to the May 14 close.
Traded Mon, Mar 29. Filed Wed, Mar 31, 8:00 PM ET, after the close. Returns use the Apr 1 open and the May 14 close. Not investment advice.